Lining up liquidity, figuring out the federal stimulus packages
We checked in again with Eric Jordahl, a capital markets expert at Kaufman Hall, about what healthcare CFOs may be working on amid the COVID-19 epidemic and the economic consequences of social distancing. Jordahl told us a little over a week ago that CFOs were contacting their relationship banks, seeking lines of credit or making plans to do so depending on their organizations' short-term liquidity needs. Here is what he had to say:
That work is continuing. Banks are getting inundated with requests, not just from healthcare but pretty much every segment of the economy is trying to do the same thing - the lining up of liquidity. I think the primary level of external liquidity formation is ongoing.
The second thing that has come out is the federal stimulus packages. I think finance teams are busy trying to understand two things. The first is, what kind of dollars might those generate for their organizations? And when might they use those dollars for liquidity purposes.
[Consider the advanced payment mechanism.] Basically, the way that works is you have to start repaying it after a certain amount of time so it is an advance on things. If [the repayment] is a certain number of days after you start utilizing it, when do you sequence that? That is the kind of thinking going on.
Related: This Week in the C-Suite
The third part is trying to put in place financial forecasting models that might be able to help describe on a rolling basis what changing liquidity needs will look like.
If all of this magically clears out in a month, that is going to produce one level of liquidity issues.
If this goes on for six months, it is a whole other thing. So trying to understand the different scenarios, what the liquidity gaps look like going forward are paramount.
I don’t think there is such great modeling out there because there is so much uncertainty.
Emerging Therapies Committee at UC Davis Hits the Accelerator Not the Brake | AMCP 2024
April 18th 2024After the onboarding of cell and gene therapy bogged using normal pharmacy and therapeutics (P&T) committee procedures, UC Davis Health set up an emerging therapeutics committee to streamline and speed up the process of delivery expensive cell and gene therapies.
Read More
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
April 18th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More